Skip to main content
OICS v0.4.1 class · Healthcare

Clinical-Stage Biotech

ID CLB HC.PH.BIO.CLB

Develops drugs, biologics or cell and gene therapies with no approved product on the market (no revenue, or milestones only); such a developer is here, not in contract research.

Sector, group and industry above this class, as placed in the current release. The sector and the industry link to their companies.

Sector
HC Healthcare in the standard Medicines, medical technology and the delivery of care.
Group
HC.PH Medicines & Life Sciences Developing and making medicines, and the tools and services for it.
Industry
HC.PH.BIO Biotechnology in the standard Biology-based drug developers.

Companies whose primary class this is. The sector and industry pages and the screener count them the same way.

Counted by primary class: every company classified here, including delisted companies and companies without filings.

Company Ticker Country Market cap Filings
Regencell Bioscience Holdings Ltd RGC United States of America $11.92Bas of 30 May 2026 88
ABIVAX ABVX France $11.13Bas of 8 Jul 2026 1,213
Summit Therapeutics Inc. SMMT United States of America $10.53Bas of 12 Jun 2026 612
Kymera Therapeutics, Inc. KYMR United States of America $9.82Bas of 13 Jul 2026 736
Nuvalent, Inc. NUVL United States of America $9.74Bas of 11 Jun 2026 610
Praxis Precision Medicines, Inc. PRAX United States of America $9.36Bas of 22 May 2026 552
Vaxcyte, Inc. PCVX United States of America $8.44Bas of 2 Apr 2026 805
Protagonist Therapeutics, Inc PTGX United States of America $7.99Bas of 25 Jun 2026 736
Spyre Therapeutics, Inc. SYRE United States of America $7.67Bas of 23 Jun 2026 839
Metsera, Inc. Delisted MTSR United States of America $7.43Bas of 31 Mar 2026 113
Immunovant, Inc. IMVT United States of America $7.30Bas of 22 May 2026 671
Cidara Therapeutics, Inc. Delisted CDTX United States of America $6.96Bas of 25 Jun 2026 807
Merus N.V. Delisted MRUS Netherlands $6.83Bas of 13 Jul 2026 579
Apogee Therapeutics, Inc. APGE United States of America $6.81Bas of 22 Jun 2026 349
Arcellx, Inc. ACLX United States of America $6.73Bas of 14 Jul 2026 452
BELITE BIO, INC BLTE United States of America $6.58Bas of 2 Apr 2026 274
Centessa Pharmaceuticals plc CNTA United Kingdom $6.27Bas of 17 Jul 2026 626
CG Oncology, Inc. CGON United States of America $6.21Bas of 4 Jul 2026 269
Terns Pharmaceuticals, Inc. Delisted TERN United States of America $6.12Bas of 13 May 2026 469
Erasca, Inc. ERAS United States of America $5.76Bas of 13 Jul 2026 382
Scholar Rock Holding Corp SRRK United States of America $5.65Bas of 1 Apr 2026 717
Cogent Biosciences, Inc. COGT United States of America $5.52Bas of 14 Mar 2026 654
Oruka Therapeutics, Inc. ORKA United States of America $5.32Bas of 11 Jul 2026 1,477
CALIWAY BIOPHARMACEUTICALS CO., LTD. 6919 Taiwan $5.14Bas of 21 Jun 2026 819
Xenon Pharmaceuticals Inc. XENE Canada $5.00Bas of 8 Jun 2026 874
Tango Therapeutics, Inc. TNGX United States of America $4.65Bas of 19 Jul 2026 456
Akero Therapeutics, Inc. Delisted AKRO United States of America $4.50Bas of 10 Jul 2026 747
Dianthus Therapeutics, Inc. DNTH United States of America $4.44Bas of 2 Apr 2026 686
Viking Therapeutics, Inc. VKTX United States of America $4.02Bas of 7 Apr 2026 684
Dyne Therapeutics, Inc. DYN United States of America $3.92Bas of 20 Jul 2026 828
ALUMIS INC. ALMS United States of America $3.79Bas of 10 Jul 2026 276
Arcus Biosciences, Inc. RCUS United States of America $3.64Bas of 13 Jul 2026 657
Edgewise Therapeutics, Inc. EWTX United States of America $3.58Bas of 5 Apr 2026 462
Structure Therapeutics Inc. GPCR United States of America $3.06Bas of 17 Jun 2026 299
Relay Therapeutics, Inc. RLAY United States of America $2.95Bas of 6 Jun 2026 619
Zealand Pharma ZEAL Denmark $2.94Bas of 9 Jul 2026 1,720
Disc Medicine, Inc. IRON United States of America $2.91Bas of 6 Jul 2026 832
Vera Therapeutics, Inc. VERA United States of America $2.88Bas of 8 Jul 2026 502
uniQure N.V. QURE Netherlands $2.84Bas of 8 Jul 2026 979
MBX Biosciences, Inc. MBX United States of America $2.69Bas of 15 Jul 2026 269
Atai Beckley N.V. ATAI Netherlands $2.67Bas of 21 Jul 2026 318
Celldex Therapeutics, Inc. CLDX United States of America $2.65Bas of 25 Jun 2026 1,300
Immunome Inc. IMNM United States of America $2.64Bas of 13 Jul 2026 486
SELLAS Life Sciences Group, Inc. SLS United States of America $2.51Bas of 14 Jul 2026 1,260
Trevi Therapeutics, Inc. TRVI United States of America $2.49Bas of 26 Jun 2026 577
IDEAYA Biosciences, Inc. IDYA United States of America $2.49Bas of 7 Jun 2026 553
Beam Therapeutics Inc. BEAM United States of America $2.47Bas of 2 Apr 2026 560
Pharvaris N.V. PHVS Netherlands $2.44Bas of 20 Jul 2026 366
Maze Therapeutics, Inc. MAZE United States of America $2.36Bas of 25 Mar 2026 236
NEKTAR THERAPEUTICS NKTR United States of America $2.32Bas of 23 May 2026 1,920

Companies in Biotechnology → Open in the screener →

Other names for this activity, and where neighboring activities go instead.

Also known as

preclinicaldrug developer

Not here
Commercial Biotech CMB HC.PH.BIO.CMB

Research-led company whose approved medicines, new substances it discovered, in-licensed or acquired, are in one or two therapeutic areas; it moves to Branded Prescription Drugs only after two consecutive annual reports with approved products in three or more. Approved new formulations of approved substances -> HC.PH.PHA.GNX.

https://financialfilings.com/oics/CLB/

This page is keyed by the class ID CLB. IDs freeze at v1.0; from then on an ID is never renamed or reused, and if the class moves in the tree, its ID and this URL stay the same.

See it in the full standard Download the standard